Are unadjusted analyses of clinical trials inappropriately biased toward the null?
- PMID: 19164784
- PMCID: PMC2693723
- DOI: 10.1161/STROKEAHA.108.532051
Are unadjusted analyses of clinical trials inappropriately biased toward the null?
Comment on
-
Should stroke trials adjust functional outcome for baseline prognostic factors?Stroke. 2009 Mar;40(3):888-94. doi: 10.1161/STROKEAHA.108.519207. Epub 2009 Jan 22. Stroke. 2009. PMID: 19164798
References
-
- Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007 Sep 12;298(10):1209–12. - PubMed
-
- Kent DM, Hayward RA. When averages hide individual differences in clinical trials. American Scientist. 2007;95:60–8.
-
- Gray LJ, Bath P, Collier T. Should stroke trials adjust for functional outcome for baseline prognostic factors? Stroke - PubMed
-
- Choi SC. Sample size in clinical trials with dichotomous endpoints: use of covariables. Journal of Biopharmaceutical Statistics. 1998 Jul.8(3):367–75. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
